Its interesting to raise the point about chasing an orphan disease target. The focus upon Leukaemia/Lymphona is described in the presentation as an unmet clinical need vis-a-vis commercial opportunity. Establishing a clinical result for an orphan disease will also open the door in more than 7-in-10 cancer cases which depend upon the mutant MYC gene.
PYC Price at posting:
1.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)